Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen.
Coradini
Danila
D
Gariboldi
Manuela
M
Fedeli
Maya
M
Pierotti
Marco A
MA
Daidone
Maria Grazia
MG
D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D051927:CD24 Antigen / Q000032:analysis; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis; D009361:Neoplasm Invasiveness; D011960:Receptors, Estrogen / Q000032:analysis*; D013629:Tamoxifen / Q000627:therapeutic use*
D051927:CD24 Antigen; C497889:CD24 protein, human; C497483:CD44 protein, human; D018960:Hyaluronan Receptors; D011960:Receptors, Estrogen; D013629:Tamoxifen